News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,004 Results
Type
Article (43253)
Company Profile (405)
Press Release (655346)
Section
Business (208719)
Career Advice (2490)
Deals (36050)
Drug Delivery (88)
Drug Development (83465)
Employer Resources (171)
FDA (16315)
Job Trends (15132)
News (352917)
Policy (33211)
Tag
Academia (2658)
Africa (801)
Alliances (50637)
Alzheimer's disease (1197)
Approvals (16228)
Arizona (183)
Artificial intelligence (74)
Asia (38533)
Australia (6448)
Bankruptcy (361)
Best Places to Work (11545)
Biotechnology (304)
C2C Services and Suppliers (79912)
California (1975)
Canada (947)
Cancer (525)
Career advice (2081)
Cell therapy (135)
China (151)
Clinical research (65203)
Collaboration (155)
Colorado (81)
Compensation (83)
Connecticut (79)
COVID-19 (2594)
Cystic fibrosis (77)
Data (324)
Diabetes (83)
Diagnostics (6053)
Drug pricing (75)
Earnings (84989)
Employer resources (146)
Europe (84087)
Events (111482)
Executive appointments (160)
FDA (16548)
Florida (270)
Funding (156)
Gene therapy (106)
GLP-1 (563)
Government (4425)
Healthcare (19067)
Hotbed/Location (489425)
Illinois (267)
Indiana (150)
Infectious disease (2624)
Inflammatory bowel disease (98)
Interviews (454)
IPO (16522)
Job creations (3738)
Job search strategy (1757)
Kansas (96)
Layoffs (425)
Legal (7964)
Lung cancer (118)
Manufacturing (91)
Maryland (413)
Massachusetts (1637)
Medical device (13232)
Medtech (13237)
Mergers & acquisitions (19393)
Metabolic disorders (270)
Michigan (124)
Minnesota (221)
Neuroscience (1356)
New Jersey (599)
New York (614)
NextGen Class of 2024 (6798)
Non-profit (4598)
North Carolina (643)
Northern California (843)
Obesity (162)
Ohio (107)
Opinion (204)
Patents (76)
Pennsylvania (590)
People (57445)
Pharmaceutical (80)
Phase I (20368)
Phase II (28763)
Phase III (21358)
Pipeline (114)
Postmarket research (2603)
Preclinical (8740)
Press Release (67)
Radiopharmaceuticals (246)
Rare diseases (140)
Real estate (6030)
Recruiting (66)
Regulatory (21790)
Research institute (2422)
Resumes & cover letters (402)
South America (1169)
Southern California (787)
Startups (3763)
Texas (253)
United States (8966)
Vaccines (506)
Washington State (264)
Weight loss (144)
Date
Last 7 days (626)
Last 30 days (2445)
Last 365 days (38135)
2024 (27160)
2023 (41106)
2022 (52385)
2021 (56914)
2020 (55115)
2019 (47753)
2018 (36014)
2017 (33262)
2016 (32661)
2015 (38674)
2014 (32426)
2013 (27385)
2012 (29478)
2011 (30128)
2010 (28244)
699,004 Results for "good therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
11 Signs of Good Company Culture
Good company culture is a crucial aspect of professional life. Look at these 11 important indications of good workplace culture before accepting a job offer or use them to evaluate your new employer.
September 19, 2024
·
4 min read
·
Editorial Staff
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Deals
Future Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.
Future Pak, LLC and its affiliates announced that it has submitted a final attempt to engage with Vanda Pharmaceuticals Inc. in a good faith effort to acquire all outstanding shares of Vanda.
June 13, 2024
·
4 min read
BioMidwest
Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy
Nika Pharmaceuticals, Inc. introduces its plans to develop the company into a sustainable business project that will consistently grow, bring good profits and provide dividends to its shareholders.
June 3, 2024
·
5 min read
Drug Development
iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
iECURE, Inc. announced today that the Australian Therapeutic Goods Administration (TGA) has approved the Company’s Clinical Trial Notification (CTN) for ECUR-506 (formerly GTP-506), an investigational therapy in development for the treatment of Ornithine Transcarbamylase (OTC) deficiency in pediatric (or neonatal) patients.
December 13, 2023
·
7 min read
Recce Pharmaceuticals Completes 5,000 RECCE® 327 Doses a Week under Good Manufacturing Practice (GMP)
Recce Pharmaceuticals Ltd today announced the successful batch completion under Good Manufacturing Practices (GMP) for its lead candidate, RECCE® 327 (R327), with the patented manufacturing process now producing 5,000 GMP doses of R327 per week.
April 17, 2024
·
4 min read
Biotech Beach
Plandai Biotechnology, Inc. Announces Rescission of Material Definitive Agreement with Good Salt, LLC
Plandai Biotechnology, Inc. announces the rescission of a material definitive agreement with Good Salt, LLC due to the material failure of consideration in the transaction.
August 1, 2023
·
1 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Press Releases
Akeso’s Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
September 16, 2024
·
2 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
1 of 69,901
Next